Is ⁶⁸Ga-Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography Ready To Simplify the Conundrum of Biochemically Recurrent Prostate Cancer?

Thenappan Chandrasekar¹, Piet Ost², Derya Tilki³

Affiliations

¹ Division of Urology, Department of Surgical Oncology, University Health Network and Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada.
² Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
³ Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: d.tilki@uke.de.

PMID: 29472144
DOI: 10.1016/j.eururo.2018.01.029

Editorial

Is ⁶⁸Ga-Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography Ready To Simplify the Conundrum of Biochemically Recurrent Prostate Cancer?

Thenappan Chandrasekar et al. Eur Urol. 2018 May.

. 2018 May;73(5):662-663.

doi: 10.1016/j.eururo.2018.01.029. Epub 2018 Feb 19.

Authors

Thenappan Chandrasekar¹, Piet Ost², Derya Tilki³

Affiliations

¹ Division of Urology, Department of Surgical Oncology, University Health Network and Princess Margaret Cancer Centre, University of Toronto, Ontario, Canada.
² Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium.
³ Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address: d.tilki@uke.de.

PMID: 29472144
DOI: 10.1016/j.eururo.2018.01.029

No abstract available

PubMed Disclaimer

Comment in

Re: Isabel Rauscher, Charlotte Düwel, Bernhard Haller, et al. Efficacy, Predictive Factors, and Prediction Nomograms for ⁶⁸Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy. Eur Urol 2018;73:656-61: Clinical Significance of Prostate-specific Membrane Antigen Immunohistochemistry and Role of the Uropathologists.
Cimadamore A, Scarpelli M, Cheng L, Lopez-Beltran A, Montorsi F, Montironi R. Cimadamore A, et al. Eur Urol. 2018 Dec;74(6):e141-e144. doi: 10.1016/j.eururo.2018.07.034. Epub 2018 Aug 6. Eur Urol. 2018. PMID: 30093173 No abstract available.

Comment on

Efficacy, Predictive Factors, and Prediction Nomograms for ⁶⁸Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy.
Rauscher I, Düwel C, Haller B, Rischpler C, Heck MM, Gschwend JE, Schwaiger M, Maurer T, Eiber M. Rauscher I, et al. Eur Urol. 2018 May;73(5):656-661. doi: 10.1016/j.eururo.2018.01.006. Epub 2018 Jan 19. Eur Urol. 2018. PMID: 29358059

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Is ⁶⁸Ga-Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography Ready To Simplify the Conundrum of Biochemically Recurrent Prostate Cancer?

Affiliations

Is ⁶⁸Ga-Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography Ready To Simplify the Conundrum of Biochemically Recurrent Prostate Cancer?

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous